20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Nutritional composition for wound healing
#5102Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels
#5103Bioactive complexes compositions and methods of use thereof
#5104FAMILY OF GENES ENCODING APOPTOSIS-RELATED PEPTIDES, PEPTIDES ENCODED THEREBY AND METHODS OF USE THEREOF
#5105Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions
#5106Adeno-associated virus-mediated survivin mutants and methods related thereto
#5107Uses of human Zven proteins and polynucleotides
#5108Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
#5109Sperm protective polypeptides and uses thereof
#5110STAT3 agonists and antagonists and therapeutic uses thereof
#5111Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
#5112Diagnosis and treatment of tumor-suppressor associated disorders
#5113XAF genes and polypeptides: methods and reagents for modulating apoptosis
#5114Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#5115FAMILY OF GENES ENCODING APOPTOSIS-RELATED PEPTIDES, PEPTIDES ENCODED THEREBY AND METHODS OF USE THEREOF
#5116Purified amniotic membrane compositions and methods of use
#5117Method to control tumor progression and invasiveness
#5118Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same
#5119Human cathelicidin antimicrobial peptides
#5120Nutraceutical composition comprising soluble keratin or derivative thereof
#5121Methods and compositions for the treatment of meconium aspiration syndrome
#5122Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof
#5123Inducing expression of puma to reduce joint inflammation in the treatment of arthritis
#5124Uses of human Zven proteins and polynucleotides
#5125Uses of humans zven proteins and polynucleotides
#5126Uses of human Zven proteins and polynucleotides
#5127Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
#5128Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
#5129Inhibition of STAT3 signal transduction for human cancer therapy
#5130Hsp therapy in conjunction with a low antigenicity diet
#5131Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes
#5132Chaperonin-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release formulation, and method of producing antibody against target protein
#5133Method for determining the susceptibility of a subject to infection
#5134Method of identifying an antiviral agent
#5135Therapeutiv preparation for hematopoietic disease
#5136Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with Hsp20
#5137Modified annexin compositions and methods of using same
#5138Composition and method for nerve regeneration
#5139Polyvalent multimeric composition containing active polypeptides, pharmaceutical compositions and methods of using the same
#5140Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
#5141USES OF HUMAN ZVEN ANTAGONISTS
#5142USES OF HUMAN ZVEN ANTAGONISTS
#5143Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#5144Methods of modulating gastrointestinal contractility
#5145Methods of detecting or diagnosing inflammatory bowel disease using prokineticin polynucleotides
#5146Method of treating dopaminergic and GABA-nergic disorders
#5147Use of human Zven proteins and polynucleotides
#5148Pharmaceutical compositions comprising an epitope of platelet gpiiia protein
#5149Vav inhibition in graft rejection
#5150Agents for preventing and/or treating uppper digestive tract disorders
#5151Galectin 9-inducing factors
#5152High throughput biological heart rate monitor that is molecularly determined
#5153Stimulation of cellular regeneration and differentiation in the inner ear
#5154NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#5155Use of calcium binding proteins to improve cardiac contractile function
#5156Human cathelicidin antimicrobial peptides
#5157Compounds useful in coating stents to prevent and treat stenosis and restenosis
#5158Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury
#5159Cytokine receptor modulators and method of modulating cytokine receptor activity
#5160HLA-A24 binding cancer antigen peptide derived from livin
#5161Cyclic amp response element activator proteins and uses related thereto
#5162Lentiviral apoe2 gene therapy
#5163Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
#5164Anti-pathogen treatments
#5165Pharmaceutical agents
#5166Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
#5167Method of treating neurological diseases
#5168Regeneration of pancreatic islets by amniotic fluid stem cell therapy
#5169XIAP-targeted prostate cancer therapy
#5170Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2
#5171Methods for reducing viral load in HIV-1-infected patients
#5172METHODS FOR ENHANCING THE EFFICACY OF CANCER THERAPY
#5173Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
#5174Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith
#5175Novel agent for inducing apoptosis comprising Msx1 or a gene encoding the same as an active ingredient
#5176Model of autoimmune disease and methods for identifying agents against autoimmune disease
#5177Paralytic peptide for use in neuromuscular therapy
#5178Modified annexin compositions and methods of using same
#5179Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
#5180Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
#5181Reduction in myocardial infarction size
#5182INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES
#5183Glucocerebroside treatment of liver disorders
#5184Methods and compositions for the inhibition of stat5 in prostate cancer cells
#5185Method for treating amyloid disease
#5186Biomarkers of resistance to infections in humans and biological applications thereof
#5187Methods and compositions for regulating T cell subsets by modulating transcription factor activity
#5188Novel use of antisecretory factor
#5189Protein involved in ovarian cancer
#5190Method and means for treatment of osteoarthritis
#5191Compositions and methods for nerve regeneration
#5192Bex4 nucleic acids, polypeptides, and method of using
#5193Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
#5194Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
#5195Low dose histone peptide treatment for autoimmune disorders
#5196Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy
#5197Treatment and Diagnosis of Insulin-Resistant States
#5198Gmg-2 polynucleotides and polypeptides and uses thereof
#5199Methods of inhibiting secretion of follicle-stimulating hormone and testosterone
#5200Method and compositions for treating hepatocellular cancer
#5201Retinoid replacements and opsin agonists and methods for the use thereof
#5202Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
#5203Methods and compositions for modulating vascular integrity
#5204S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
#5205Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
#5206Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
#5207Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
#5208Fugetactic proteins, compositions and methods of use
#5209Hip/pap polypeptide compositions for use in liver regeneration and for the prevention of liver failure
#5210Use of substances inhibiting the association of said protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp
#5211Anti-inflammatory agents and methods of their use
#5212Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration
#5213Use of an agent that restores tissue perfusion and oxygenation
#5214Activity of THAP-family chemokine-binding domains
#5215Stabilization of hypoxia inducible factor (HIF) alpha
#5216Compositions of THAP-family chemokine binding domains
#5217Compositions of THAP-family chemokine binding domains
#5218Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
#5219Compounds and Methods for Promoting Angiogenesis
#5220Chemically modified novel erythropoietin stimulating protein compositions and methods
#5221Identification of agonistic autoantibodies
#5222Pharmaceutical composition containing decoy and use of the same
#5223Apolipoprotein L-I and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by
#5224Stabilization of hypoxia inducible factor (HIF) alpha
#5225Stabilization of hypoxia inducible factor (HIF) alpha
#5226Compositions and methods of treating HIV infections
#5227Decorin proteoglycan inhibitor of fibrinogen blood clotting
#5228Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
#5229Multimeric apoprotein agonists
#5230Inhibitors for use in hemostasis
#5231Postsynaptic proteins
#5232Targeted vectors for cancer immunotherapy
#5233Augmented cognitive training
#5234Metabolic gene polynucleotides and polypeptides and uses thereof
#5235Method of improving learning and memory in mammals
#5236Slim compositions and methods of use thereof
#5237Modulation of the synthesis of insulin
#5238Method of increasing the salivary sialic acid content in a mammal
#5239Neuroprotective effects of atf6
#5240Decoy composition for treating and preventing inflammatory disease
#5241Therapeutic agent for Abeta related disorders
#5242Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome
#5243Biocidal molecules, macromolecular targets and methods of production and use
#5244Activity of THAP-family chemokine-binding domains
#5245Neuronal regeneration and compound administration methods
#5246Methods for treating cancers and restenosis with p21
#5247Rhesus HER2/neu, nucleotides encoding same, and uses thereof
#5248Extracellular matrix binding chimeric proteins and methods of use thereof
#5249Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#5250RasGAP derived peptide for selectively killing cancer cells
#5251Embryo implantation inhibitor
#5252Methods for improving the structure and function of arterioles
#5253Use of IL-18BP for treatment of peripheral vascular diseases
#5254Hypoxia induced mitogenic factor
#5255Methods for modulating topical inflammatory response
#5256NELL-1 enhanced bone mineralization
#5257Constructs binding to phosphatidylserine and their use in disease treatment
#5258Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
#5259Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
#5260Methods and compositions for selecting cells with increased potency
#5261Charged lipoprotein complexes and their uses
#5262Methods for regulating inflammatory mediators and peptides useful therein
#5263Systemic treatment of infections with defensins
#5264Use of ghrelin for treating malnutrition in gastrectomized individuals
#5265Peptides having an ace inhibiting effect
#5266Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy
#5267METHOD OF TREATING SKIN USING COMPOSITION INCLUDING CHAPERONIN PROTEINS
#5268Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1
#5269Novel agent for improving neurotransmission failure
#5270Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
#5271Stem cell-derived factors for treating pathologic conditions
#5272Novel compositions and methods for cancer
#5273Dental products comprising bone growth enhancing peptide
#5274Custom-made meganuclease and use thereof
#5275Methods for increasing cell and tissue viability
#5276Hypoxia inducible factor 2α for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension
#5277Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
#5278Apoptosis inducing agent and method for inducing apoptosis
#5279Alpha-fetoprotein peptides and uses thereof
#5280Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
#5281Chaperonin 10 immunosuppression
#5282NOD1 as an anti-tumor agent
#5283Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
#5284Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
#5285Conversion of apoptotic proteins
#5286Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen
#5287Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
#5288Neuropeptide Y receptor Y5 and nucleic acid sequences
#5289COMPOSITIONS CONTAINING AN INTESTINAL TREFOIL PEPTIDE AND A MUCOADHESIVE
#5290Preventing/remedies for cancer
#5291Viral vectors
#5292Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
#5293Methods of increasing endogenous erythropoietin (EPO)
#5294Treatment of anemia
#5295Methods for assessing p19-Arf interactions in cMyc
#5296Therapies for cancer using RLIP76
#5297Methods of increasing endogenous erythropoietin (EPO)
#5298Methods of increasing endogenous erythropoietin (EPO)
#5299Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor
#5300Modulation of the neuroendoctrine system as a therapy for motor neuron disease
#5301Steroid conjugates, preparation thereof and the use thereof
#5302Preparation of a therapeutic composition
#5303Human neutrophil alpha-defensin 4 inhibition of HIV-1
#5304Restoring vascular function
#5305Antimicrobial agent
#5306Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#5307MKK7 activation inhibitor
#5308Method for modulating epithelial stem cell lineage
#5309Reversible pegylated drugs
#5310Treatment and/or prevention of non-viral epithelial damage
#5311Control of function of intracellular Ca ion
#5312Methods for modulating telomerase activity
#5313Zinc transporter compositions for the treatment of cardiovascular diseases
#5314Chimeric tumor suppressor gene and protein
#5315Gene therapy of tumors using non-viral delivery system
#5316Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
#5317Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
#5318Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
#5319Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
#5320Engineered intervertebral disc tissue
#5321Phosophoinositoglycan binding proteins
#5322Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
#5323Transcriptional factor inducing apoptosis in cancer cell
#5324Seed tear resistant scaffold
#5325Growth factor encapsulation system for enhancing bone formation
#5326GD2 ligands
#5327Stem cells for use in locating and targeting tumor cells
#5328Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#5329Cancer immunotherapy incorporating p53
#5330Isolation and method of using tissue growth-inducing Frzb
#5331Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#5332Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
#5333Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors
#5334Monocyte chemoattractant activity of galectin-3
#5335Methods for treating and preventing brain cancers
#5336Method for treating tumor and/or preventing tumor metastasis and relapse
#5337Vault and vault-like carrier molecules
#5338Compositions and methods for treating female fertility
#5339Biocides
#5340Protein formulation
#5341Gene expression and genetic changes implicated in alcoholism
#5342Protein modification
#5343Methods and compounds for treating brain amyloidosis
#5344Packaging of positive-strand RNA virus replicon particles
#5345Proteic binding partners of TCTP and methods of modulating tumor reversion or cell apoptosis
#5346Platlet glycoprotein Ib alpha fusion polypeptides and methods of use thereof
#5347Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
#5348Methods for the treatment of alzheimers disease and compositions therefore
#5349Therapeutic formulations for the treatment of beta-amyloid related diseases
#5350Drugs containing galectin 9
#5351Preventives/remedies for cancer
#5352Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor
#5353Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer
#5354Sustained improver of muscular fatigue
#5355RAG polypeptides, nucleic acids, and their use
#5356Notch signaling in long-term memory formation
#5357Methods for blocking adipocyte differentiation and triglyceride accumulation with transcription factor dp-1 inhibitors
#5358Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system
#5359Method of modulating cellular activity and molecules for use therein
#5360Methods and preparations for curing critically ill patients
#5361Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor
#5362Compounds and methods for detection of carcinomas and their precursor lesions
#5363Compositions and methods for WT1 specific immunotherapy
#5364Method and composition for regulating the activity of regulatory t cells
#5365Neoadjuvant genetic compositions and methods
#5366Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof
#5367Disease treatment via antimicrobial peptide inhibitors
#5368Method for treating or preventing metastasis of colorectal cancers
#5369Nell-1 enhanced bone mineralization
#5370Methods for preventing and treating Alzheimer's disease
#5371Treatment of type I diabetes
#5372Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
#5373Prevention therapy and prognosis/monitoring in sepsis and septic shock
#5374DAP-10 and uses thereof
#5375MDA-7 and free radicals in the treatment of cancer
#5376Modified annexin proteins and methods for their use in organ transplantation
#5377Polypeptide
#5378Use of uk114 in the treatment of leishmaniasis
#5379Modulation of stem cell differentiation by modulation of caspase-3 activity
#5380Protein and fruit juice product
#5381Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site
#5382Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft
#5383Compositions and methods for the transport of biologically active agents across cellular barriers
#5384Method of preventing or treating liver disease
#5385Pancreatic polypeptide family motifs and polypeptides comprising the same
#5386Platelet glycoprotein Ib alpha fusion polypeptides and methods of use thereof
#5387Use of heat shock proteins to enhance efficacy of antibody therapeutics
#5388Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target
#5389Cd26-based therapies for cancers and immune disease
#5390Sperm specific lysozyme-like proteins
#5391Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
#5392Treatment for dry eye syndrome
#5393Tissue factor compositions and methods
#5394IGF-BP3-related methods for inhibiting tumor growth
#5395Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#5396Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
#5397Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same
#5398Inhibition of Smad3 to prevent fibrosis and improve wound healing
#5399Stabilized A-beta protofibrillar aggregates
#5400Methods and compositions for treating hypercholesterolemia